4//SEC Filing
McKenzie Kathryn B 4
Accession 0001077183-22-000002
CIK 0001077183other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 6:50 PM ET
Size
12.3 KB
Accession
0001077183-22-000002
Insider Transaction Report
Form 4
McKenzie Kathryn B
Principal Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2022-01-11$9.07/sh+2,100$19,047→ 49,361 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-11−2,100→ 17,900 totalExercise: $9.07Exp: 2022-10-18→ Common Stock (2,100 underlying)
Holdings
- 35,171
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (35,171 underlying) - 13,894
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (13,894 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (40,000 underlying) - 37,514
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (37,514 underlying)
Footnotes (5)
- [F1]On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F2]On February 26, 2018, Ms. McKenzie was granted 48,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Ms. McKenzie was granted 13,894 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2021, Ms. McKenzie was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001720001
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 6:50 PM ET
- Size
- 12.3 KB